English
Español
CONTACT US
HOME

ONCOMATRYX

pioneering stromal medicine

Menu

ABOUT
DRUG DISCOVERY
DIAGNOSTICS
COMPANION DX
- COMPANION DIAGNOSTICS
BLOG
CONTACT

Month: October 2018

Poster Presentation at ESMO 2018 Congress

Poster Presentation at ESMO 2018 Congress

ESMO 2018 Congress Munich, Germany – 19 Oct – 23 Oct 2018 Myriam Fabre, PhD. (Oncomatryx R&D Director) presents the poster: OMTX705, a powerful stroma-targeting ADC to treat invasive tumors with

Oncomatryx2018-10-032019-10-11 NEWS No Comments Read more

Archives

November 2024
May 2024
May 2023
September 2022
May 2022
March 2022
November 2020
October 2018
February 2018
April 2017
February 2017
November 2016
September 2016
August 2016
April 2016
February 2016
December 2015
July 2015
May 2015
June 2013
January 2013

Meta

Log in

UE Next Generation

This company is capitalized by INNVIERTE, AN INVESTMENT PROGRAM OF CDTI, E.P.E.

PRECISION DRUGS

PRECISION DRUGS
ANTIBODY DRUG CONJUGATES
PIPELINE

DIAGNOSTICS

COL11A1 BIOMARKER
INVASIVE TUMOR DIAGNOSTICS -invaScan-
BLADDER CANCER DIAGNOSTICS -bladderScan-

With the collaboration of:

ONCOMATRYX BIOPHARMA SL ©2019

English
Español
TERMS OF USE
PRIVACY POLICY
SITE MAP

By continuing to use the site, you agree to the use of cookies. Continue, scroll or accept. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.